Cargando…
The impact of pharmaceutical innovation on the burden of disease in Canada, 2000–2016
We perform an econometric assessment of the role that pharmaceutical innovation—the introduction and use of new drugs—has played in reducing the burden of disease in Canada, by investigating whether diseases for which more new drugs were launched had larger subsequent reductions in disease burden. S...
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6698939/ https://www.ncbi.nlm.nih.gov/pubmed/31440578 http://dx.doi.org/10.1016/j.ssmph.2019.100457 |